期刊文献+

肾素-血管紧张素系统基因多肽性与IgA肾病的关系 被引量:4

Relationship between renin angiotensin system gene polymorphism and IgA nephropathy
下载PDF
导出
摘要 目的了解血管紧张素原(AGT)、血管紧张素转换酶(ACE)、血管紧张素Ⅱ1受体(AT1R)基因多肽对IgA肾病的发生发展的影响。方法选择了64例IgA肾病患者和80例健康献血者,分别测定AGT、ACE和AT1R基因多肽性,并观察患者的尿蛋白,肾功能、血压。结果①患者具有ACE DD基因型者24小时尿蛋白定量(2.59±0.75)g明显高于ACEⅡ基因型者(1.80±0.57)g,两组间差异具有统计学意义(P<0.01);ACE DD基因型患者的血肌酐(134.0±22.5)μmol/L明显高于ACEⅡ基因型患者(92.0±19.2)μmol/L,两组间差异具有统计学意义(P<0.01)。②具有AGT TT基因型患者的24 h尿蛋白定量(2.32±0.78)g,明显高于AGT MM基因型(1.79±0.58)g和MT基因型(1.87±0.63)g,差异具有统计学意义(P<0.01);具有AGT TT基因型患者的血肌酐(135.0±23.8)μmol/L明显高于AGT MM基因型(98.9±17.3)μmol/L和MT基因型(105.1±25.3)μmol/L,差异具有统计学意义(P<0.01)。③患者具有AT1R AA AC CC基因型之间血压、血肌酐、24 h尿蛋白定量差异无统计学意义。④ACE与AGT联合作用结果发现ID+TT组24 h尿蛋白(2.10±0.81)g高于其他基因组,血肌酐(110.4±25.7)μmol/L高于其他基因组,但差异无统计学意义(P>0.05)。DD+TT组及DD+MT亦有24 h尿蛋白升高的趋势,但无统计学意义。结论肾素-血管紧张素系统的基因多肽性与IgA肾病进展相关。联合基因分析结果无统计学意义。提示需加大样板数,加入IgA肾病其他易感基因联合分析。 Objective To investigate the influence on IgA nephropathy evolution from gene polymorphism of angiotensinogen(AGT),angiotensin-conventing enzyme(ACE),angiotensin Ⅱ 1 receptor(AT1R). Methods Sixty-four cases of IgA nephropathy patients and 80 cases of health blood donors were respectively measured their gene polymorphism from AGT ACE AT1 R, and patients' urinary protein, renal function, blood pressure were tested. Results 024 hour urinary protein excretion quantity was obviously much higher from the patients with ACE DD gene (2.59 ± 0.75) g than the Ones with ACE Ⅱ gene (1.80±0.57) g( P 〈0.01). The serum creatinine was obviously higher from the patents with ACE DD gene (134.0±22.5) μmol/L than the ones with ACE Ⅱ gene(92.0±19.2) μmol/L( P 〈 0.01). (2) 24 hour urinary protein excretion quantity was obviously higher from these patients with AGT TT gene (2.32±0. 78) g,than those patients with AGT MM gene (1.79±0.58) g and MT gene (1.87±0.63) g( P 〈0.01). The difference among the three groups showed significance difference. The serum creatinine was obviously higher from the patients with AGT TT gene(135. 0±23. 8) μmol/L,than those patients with AGT MM gene (98.9±17.3) μmol/L and MT gene (105.1 ± 25.3) μmol/L (P 〈 0.01). The difference among the three gtoups had notable statstic significance. (3)There were no notable differences on blood pressure,serum creatinine,24 hour urinary protein excretion quantity among the patients' group with ATIR AA AC CC gene. (4)By observing ACE and AGT together, 24 hour urinary protein excretion quantity was obviously higher from these patients group ID+ TT (2.10 ± 0.81) g, compared with the rest groups,also serum creatinine from group ID+ TT ( 110.4 ± 25.7) μmol/L, being the highest among the rest groups( P 〉0.05), and 24 hour urinary protein excrention quantity from DD+ TT group and DD+ MT group showed ascending tendency,but no statistic significance.
出处 《临床荟萃》 CAS 北大核心 2007年第10期685-688,共4页 Clinical Focus
关键词 肾小球肾炎 IGA 尿分析 蛋白尿 核苷类 血压 基因结构 glomerulonephritis, IGA urinalysis proteinuria nucheosides blood pressure genes, structural
  • 相关文献

参考文献14

  • 1Donadio JV,Grande JP.IgA Nephropathy[J].N Engl J Med,2002,347(10):738. 被引量:1
  • 2王朝晖,陈楠,周同.IgA肾病易感基因研究进展[J].中国微循环,2004,8(2):119-122. 被引量:7
  • 3Srephan R,Harald F,Gerd A.Mutagenically separated PCR(MS-PCR):a highly specific one step procedure for easy mutation detection[J].Nucleic Acids Research,1993,21(16):3623-3629. 被引量:1
  • 4郑欣,章友康,李晓雁,朱世乐,白千帆,鄂洁.血管紧张素转换酶基因多态性与IgA肾病的相关性研究[J].中华肾脏病杂志,1999,15(6):379-380. 被引量:3
  • 5Floege J.Evidence-based recommendations for immunosuppression in IgA nephropathy:handle with eaution[J].Nephrol Dial Transplant,2003,18(2):241-245. 被引量:1
  • 6Syrijanen J,Huang XH,Mustonen J,et al.Angiotensin-converting syrjanen insertion/deletion polymorphism and prognosis of IgA nephropathy[J].Nephron,2000,86(2):115-121. 被引量:1
  • 7Stratta P,Canavese C,Ciccone G,et al.Angiotensin I-Converting enzyme genotype significantly affects progression of IgA glomerulonephritis in an Italian population[J].Am J Kidney Dis,1999,33(6):1071-1079. 被引量:1
  • 8Goto S,Narita I,Saito N,et al.A(-20) C polymorphism of the angiotensinogen gene and progression of IgA nephropathy[J].Kidney Int,2002,63(3):980-985. 被引量:1
  • 9Gharavi AG,Yan Y,Scolan F,et al.IgA nephropathy,the most common cause of glomerulonephritisis linked to 6q22-23[J].Nat Genet,2000,26(3):354-357. 被引量:1
  • 10Matsunaga A,Numakura C,Kawakami T,et al.Association of the uteroglobin genepoly morphism with IgA nephropathy[J].Am J Kidney Dis,2002,39(1):36-41. 被引量:1

二级参考文献26

  • 1陈楠,范丽安,杨言如,钱萍,顾峥,董建中,杨珏琴,董德长.人类白细胞抗原与IgA肾病关联及其临床意义[J].中国免疫学杂志,1996,12(2):85-88. 被引量:9
  • 2陈朝红,刘志红,王庆文,季曙明,季大玺,黎磊石.血管紧张素转化酶基因多态性在终末期肾功能衰竭患者中的分布及其意义[J].中华肾脏病杂志,1997,13(1):22-24. 被引量:15
  • 3Nauita I, Saito N, Goto S, et al. Role of uteroglobin G38A polymorphism in the progression of lgA nephropathy in Japanese patients[J]. Kidney Int.2002,61(5): 1853~1858. 被引量:1
  • 4Szelestei T, Bahring S, Kovacs T, et al. Association of a uteroglobin polymorphism with rate of progression in patients with IgA nephropathy [J].Am J Kidney Dis. 2000,36(3):468~473. 被引量:1
  • 5Kim YS, Kang D, Kwon DY, et al. Uteroglobin gene polymorphisms affect the progression of immunoglobulin a nephropathy by modulating the level of u teroglobin expression [J]. Pharmacogenetics. 2001,11 (4): 299~305. 被引量:1
  • 6Hsu SI, Ramirez SB, Winn MP,et al. Evidence for genetic factors in the development and progression of IgA nephropathy[J] . Kidney Int, 2000,57(5) : 1818 - 1835. 被引量:1
  • 7Akiyama F, Tanaka T, Yamada R, et al. Single-nucleotide polymorphisms in the class Ⅱ region of the major histocompatibility complex in Japanese patients with immunoglobulin A nephropathy[J] .J Hum Genet.2002,47(10) :532~538. 被引量:1
  • 8Matthews VB, Witt CS, French MA,et al. Central MHC genes affect IgA levels in the human: reciprocal effects in IgA deficiency and IgA nephropathy[J] .Hum Immunol. 2002,63(5) :424~433. 被引量:1
  • 9Li PK, Poon P, Phil M,et al. Association of lgA nephropathy with T-cell receptor constant alpha chain gene polymorhism[J]. Am J Kidney Dis.1997,30(2) :260~264. 被引量:1
  • 10Goto S, Narita I, Saito N, et al. A(-20) C polymorphism of the angiotensinogen gene and progression of IgA nephropathy[J]. Kidney Int.2002, 62(3): 980~985. 被引量:1

共引文献25

同被引文献47

  • 1杨方,柳文鉴,刘平平,何国玲,郭志强,刘佩玲.小儿肾病综合症肾素-血管紧张素系统基因多态性研究[J].暨南大学学报(自然科学与医学版),2005,26(2):246-251. 被引量:2
  • 2郭明秋,李莉,苗翠,罗兵.ACE基因和AT1R基因多态性与糖尿病相关性的研究[J].华中医学杂志,2007,31(1):25-27. 被引量:9
  • 3Donadio J V, Grande J P. IgA nephropathy[ J]. N Engl J Med, 2002, 347(10) : 738 -748. 被引量:1
  • 4Quackenbush J. Computational analysis of microarray data[ J]. Nat Rev Genet,2001,2(6) :41g -427. 被引量:1
  • 5Cummins J M, He Y, Leary R J, et al. The colorectal microRNAome [J]. Proc Natl Acad Sci U S A, 2006,103(10) : 3687 -3692. 被引量:1
  • 6Smith A C, de-Wolff J F, Molyneux K, et al. O-Glycosylation of serum IgD in IgA nephropathy[J]. J Am Soc Nephrol, 2006, 17(8-) : 1192 - 1199. 被引量:1
  • 7Espinosa M, Ortega R, Gomez-Carrasco J M, et al. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy [ J ]. Ncphrol Dial Transplant, 2008,8( 1 ) :563 -568. 被引量:1
  • 8Suzuki H, Suzuki Y, Yamanaka T,et al. Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22 - 23[J]. J Am Soc Nephrot, 2005, 16(5) : 1289 -1299. 被引量:1
  • 9Praga M, Gutierrez E, Gonzalez E, et al. Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial [ J ]. J Am Soc Nephrol, 2003, 14(6) : 1578 - 1583. 被引量:1
  • 10Calin G A, Dumitru C D, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia[J]. Proc Natl Acad Sci U S A, 2002, 99(24) : 15524 - 15529. 被引量:1

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部